TriStar Health Partners

  • Home
  • About
    • TriStar
    • Team
  • News
  • Investment Strategy
    • Investment Strategy
    • Economic Development Fund – TN Investco
  • Portfolio
  • Contact

Pathline Emerge Launches DNA Profiling Tests using GenomOncology’s GO Clinical Workbench

July 14, 2016 By tstventures2015

“Pathline Emerge takes a multi-disciplinary approach to evaluate specific types of cancer to support personalized medicine. Our full-service pathology laboratory was one of the first to obtain New York State approval for clinical NGS testing. As the demand for NGS testing and personalized medicine continues to grow and more information becomes available, better solutions are needed to quickly and thoroughly analyze the burgeoning amounts of data,” said Michael Lorenzo, VP of Operations at Pathline Emerge. “With this in mind, Pathline Emerge partnered with GenomOncology for a software solution, which allows us to streamline our workflow and deliver robust clinical reports. The GO Clinical Workbench will allow Pathline Emerge to scale efficiently while also maintaining compliance.” (read more)

Filed Under: News

Our Portfolio


VIEW MORE

Subscribe to News & Events

Contact Us

Thank you for your interest in TriStar Health Partners. If you have questions or need further information, please contact us!

TriStar Health Partners

3322 West End Ave, Suite 1100 | Nashville, TN 37203
615.515-9880

Copyright © 2023 TriStar Technology Ventures. All rights reserved (CC-licensed photos excepted).